Pricing is under design partnership terms today and depends on segment. Cancer centers and academic medical centers engage through pilot pricing with enterprise expansion after a defined 2 to 3 month validation period. CROs and Phase 1 sites engage per-trial or under platform license. Pharma sponsors engage through Protocol Safe per-trial research agreements and Postmarket Pharmacovigilance Processing platform plus per-case usage agreements. Book a 15-minute conversation to discuss pricing relevant to your organisation: https://calendly.com/nnennaj/chat-with-nnenna-john